Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07213531

Enhanced Valves Interventions and Safe AI Generated End Results

Status
Recruiting
Phase
Study type
Observational
Enrollment
21,000 (estimated)
Sponsor
Montreal Heart Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This non-interventional study aims to use artificial intelligence to improve the prediction of transcatheter heart valve interventions and optimize patient outcomes. It is based on the analysis of retrospective data from various specialized centers worldwide.

Detailed description

The ENVISAGE study is a non-interventional, retrospective research study designed to validate an artificial intelligence (AI)-based framework for the automated analysis of cardiac imaging data, including multi-slice cardiac computed tomography (CT) and transesophageal echocardiography (TEE). The primary objective is to predict the success of transcatheter heart valve interventions, including aortic, mitral, and tricuspid valve interventions (TAVI, TMVI, M-TEER, T-TEER). The AI framework developed in this study will rely on deep learning algorithms, particularly convolutional neural networks (CNNs) and other advanced models, to automatically segment critical anatomical structures and perform accurate measurements of these structures from CT and TEE images. These measurements will then be combined with pre-interventional clinical data to optimize patient selection and intervention planning, as well as to predict surgical outcomes with high accuracy. AI will also aim to reduce human error and inter-observer variability in the interpretation of cardiac images, which could significantly improve clinical outcomes.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMedical imaging analysis via artificial intelligence algorithmsDevelopment of AI algorithms based on pre-procedural imaging annotations and clinical informations to predict the transcatheter procedural outcomes

Timeline

Start date
2024-05-01
Primary completion
2028-05-01
Completion
2029-05-01
First posted
2025-10-09
Last updated
2025-10-09

Locations

15 sites across 5 countries: United States, Canada, France, Germany, Italy

Source: ClinicalTrials.gov record NCT07213531. Inclusion in this directory is not an endorsement.